Mesoblast Ltd (OTC Pink - Current Information:MBLTY)

Data as of 2:00pm ET
 -0.40 / -2.10%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Mesoblast Ltd. is engaged in the development of biotherapeutics based on its proprietary cell-based technologies. The company's technology platforms have the potential to deliver a diverse portfolio of clinical-stage products to treat a broad range of conditions with major unmet medical needs. Its products target cardiovascular conditions, diabetes, inflammatory conditions of lungs and joints, eye diseases, bone marrow cancers, bone fractures, cartilage degeneration and musculoskeletal conditions. The company operates through single segment i.e., Research and Development of Adult Mesenchymal Precursor Cells. Mesoblast was founded by Itescu Silviu on June 8, 2004 and is headquartered in Melbourne, Australia.

Contact Information

Mesoblast Ltd.
55 Collins Street
Melbourne Victoria (vic) 3000
P:(139) 639-6036
Investor Relations:



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Silviu ItescuChief Executive Officer, Executive Director & MD
Paul RennieChief Operating Officer
Paul HodgkinsonChief Financial Officer
Donna L. SkerrettChief Medical Officer
Michael WarmanExecutive Vice President-Business Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.